Rhea N. Coler

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

Lisa A. Jackson, Evan J. Anderson, Nadine Rouphael et al. · New England Journal of Medicine · 2020 · 3.4K citations · Full text

New horizons in adjuvants for vaccine development

Steven G. Reed, Sylvie Bertholet, Rhea N. Coler et al. · Trends in Immunology · 2008 · 611 citations

Vaccinology, Vaccination, Vaccine Development +4

Homologous and Heterologous Covid-19 Booster Vaccinations

Robert L. Atmar, Kirsten E. Lyke, Meagan E. Deming et al. · New England Journal of Medicine · 2022 · 603 citations · Full text

Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant

Rhea N. Coler, Sylvie Bertholet, Magdalini Moutaftsi et al. · PLoS ONE · 2011 · 310 citations · Full text

A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant <i>Mycobacterium tuberculosis</i>

Sylvie Bertholet, Gregory C. Ireton, Diane Ordway et al. · Science Translational Medicine · 2010 · 301 citations · Full text